4.6 Article

SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy

Francisco Triana-Martinez et al.

Article Medicine, Research & Experimental

Role of MAML1 in targeted therapy against the esophageal cancer stem cells

Meysam Moghbeli et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Medicine, Research & Experimental

SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway

Wenjing Zhu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Multidisciplinary Sciences

Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma

Mitsuteru Natsuizaka et al.

NATURE COMMUNICATIONS (2017)

Article Pathology

Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis

Mahnaz Hashemi Bidokhti et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2017)

Review Oncology

Hedgehog Signaling in the Maintenance of Cancer Stem Cells

Catherine R. Cochrane et al.

CANCERS (2015)

Article Oncology

Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis

Mohammad Mahdi Forghanifard et al.

PATHOLOGY & ONCOLOGY RESEARCH (2015)

Review Oncology

The Notch signaling pathway as a mediator of tumor survival

Kathleen M. Capaccione et al.

CARCINOGENESIS (2013)

Article Oncology

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

Kenneth C. Valkenburg et al.

Cancers (2011)

Article Cell & Tissue Engineering

Notch Promotes Radioresistance of Glioma Stem Cells

Jialiang Wang et al.

STEM CELLS (2010)

Article Oncology

HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil

Hasan Korkaya et al.

CLINICAL CANCER RESEARCH (2009)

Review Gastroenterology & Hepatology

WNT/β-catenin signaling in liver health and disease

Michael D. Thompson et al.

HEPATOLOGY (2007)

Review Oncology

PI3K/Akt/mTOR pathway as a target for cancer therapy

D Morgensztern et al.

ANTI-CANCER DRUGS (2005)